Concert Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
AI
Concert Wealth Management's PJP Position: Q2 2017 in Review
Concert Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 12,815 shares — an estimated $721K sold.
Concert Wealth Management first reported a position in PJP in Q2 2013 and held it in 16 quarters. The position peaked at $3.35M in Q2 2014. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.
- Concert Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
- Concert Wealth Management sold 12,815 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $721K.
- Concert Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 16 quarters.
- Concert Wealth Management's Invesco Pharmaceuticals ETF position peaked at $3.35M in Q2 2014.
- 99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.
Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.